下调lncRNA LINC00263靶向miR-4458调控乳腺癌SK-BR-3细胞放射敏感性

doi:10.3760/cma.j.cn113030-20200803-00393

摘要
图/表
参考文献(23)
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要目的研究下调lncRNA LINC00263靶向miR-4458对乳腺癌SK-BR-3细胞增殖、运动、侵袭及放射敏感性影响。方法 qRT-PCR方法分别检测乳腺癌组织、癌旁组织、正常乳腺上皮细胞和乳腺癌细胞中LINC00263表达差异。SK-BR-3细胞中转染LINC00263shRNA下调LINC00263表达,克隆实验检测放射敏感性。SK-BR-3细胞给予6Gy照射处理,CCK-8检测细胞增殖,流式细胞术检测凋亡,Transwell小室检测细胞运动和侵袭,蛋白印迹法检测C-Caspase-3、C-Caspase-9、MMP-2、MMP-9蛋白表达。生物信息学软件预测LINC00263和miR-4458有互补结合位点,荧光素酶报告系统测定二者的靶向关系。在SK-BR-3细胞中共转染LINC00263shRNA和miR-4458 inhibitor,给予6Gy照射处理,检测细胞增殖、运动、侵袭和凋亡变化。结果乳腺癌组织中LINC00263表达水平高于癌旁组织。乳腺癌细胞中LINC00263表达水平高于正常乳腺上皮细胞。转染LINC00263shRNA以后的SK-BR-3细胞放射敏感性增加。转染LINC00263shRNA和放射联合具有协同作用,共同抑制细胞增殖、运动、侵袭,促进细胞凋亡,提高细胞中C-Caspase-3、C-Caspase-9蛋白表达水平,降低细胞中MMP-2、MMP-9蛋白表达水平。下调LINC00263靶向促进miR-4458表达。miR-4458 inhibitor逆转LINC00263shRNA联合放射对SK-BR-3细胞增殖、运动、侵袭的抑制作用和凋亡促进作用。结论下调lncRNA LINC00263靶向miR-4458抑制SK-BR-3细胞增殖、运动、侵袭,提高细胞放射敏感性。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	温兰兰
	王东娟
	董辉
	赵继伟
	朱翠敏
	林萍萍
	刘兰芳
	李青山

关键词 ： LINC00263基因, miR-4458基因, 放射敏感性, SK-BR-3细胞系

Abstract：Objective To evaluate the effect of down-regulating lncRNA LINC00263 targeting miR-4458 on the proliferation, migration, invasion and radiosensitivity of breast cancer SK-BR-3 cells. Methods The expression differences of LINC00263 in breast cancer tissues, adjacent tissues, normal breast epithelial cells and breast cancer cells were determined by qRT-PCR. Transfection of LINC00263shRNA in breast cancer SK-BR-3 cells down-regulated the expression of LINC00263, and the cloning experiment was used to detect the radiosensitivity. Breast cancer SK-BR-3 cells were treated with 6Gy irradiation. CCK-8 assay was employed to detect cell proliferation. Flow cytometry was adopted to detect cell apoptosis. Transwell chamber test was performed to detect cell migration and invasion. Western blot was used to detect the expression levels of C-Caspase-3 and C-Caspase-9, MMP-2 and MMP-9 proteins. Bioinformatics software predicted that LINC00263 and miR-4458had complementary binding sites, and the luciferase reporter system was utilized determine the targeting relationship between LINC00263 and miR-4458. LINC00263shRNA and miR-4458 inhibitor were co-transfected into breast cancer SK-BR-3 cells, and 6Gy irradiation was given to detect the changes in cell proliferation, apoptosis, invasion and migration. Results The expression level of LINC00263 in breast cancer tissues was higher than that in adjacent tissues. The expression level of LINC00263 in breast cancer cells was higher compared with that in normal breast epithelial cells. The radiosensitivity of breast cancer SK-BR-3 cells was increased after transfection of LINC00263shRNA. Transfection of LINC00263shRNA and radiation exerted a synergistic effect, jointly inhibited breast cancer cell proliferation, migration and invasion, promoted cell apoptosis, up-regulated the expression levels of C-Caspase-3 and C-Caspase-9 proteins in cells, and down-regulated those of MMP-2 and MMP-9 proteins. Down-regulation of LINC00263 targetedly up-regulated miR-4458 expression. miR-4458 inhibitor reversed the inhibitory effect of LINC00263shRNA combined with radiation on the proliferation, migration, invasion and apoptosis promotion of breast cancer SK-BR-3 cells. Conclusion Down-regulating lncRNA LINC00263 targeting miR-4458 inhibits the proliferation, migration and invasion of breast cancer SK-BR-3 cells, and improves cell radiosensitivity.

Key words： LINC00263 gene miR-4458 gene Radiosensitivity SK-BR-3 cells line

收稿日期: 2020-08-03

通讯作者: 李青山,Email:tuanrana5141@126.com

引用本文:

温兰兰,王东娟,董辉等. 下调lncRNA LINC00263靶向miR-4458调控乳腺癌SK-BR-3细胞放射敏感性[J]. 中华放射肿瘤学杂志, 2021, 30(11): 1195-1201.

Wen Lanlan,Wang Dongjuan,Dong Hui et al. Effect of down-regulation of lncRNA LINC00263 targeting miR-4458 on regulating radiosensitivity of breast cancer SK-BR-3 cells[J]. Chinese Journal of Radiation Oncology, 2021, 30(11): 1195-1201.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.cn113030-20200803-00393 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2021/V30/I11/1195

[1] Rivera S, Hannoun-Lévi JM. Hypofractionated radiation therapy for invasive breast cancer:From moderate to extreme protocols[J]. Cancer Radiother, 2019, 23(8):874-882. DOI:10.1016/j.canrad.2019.09.002.
[2] Wallace AS, Keene KS, Williams CP, et al. Hypofractionated radiation in older women with breast cancer[J]. Breast J, 2019, 25(6):1206-1213. DOI:10.1111/tbj.13444.
[3] Dreyfuss AD, Barsky AR, Taunk NK, et al. The efficacy and safety of hypofractionated radiotherapy with concurrent anti-HER-2 therapy following breast-conserving therapy for breast cancer[J]. Breast J, 2019, 25(6):1097-1103. DOI:10.1111/tbj.13421.
[4] Li R, Yang YE, Jin J, et al. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1):3246-3258. DOI:10.1080/216914 01.2019.1647225.
[5] Liu L, Zhu Y, Liu AM, et al. Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185[J]. Eur Rev Med Pharmacol Sci, 2019, 23(17):7457-7468. DOI:10.26355/eurrev_201909_18855.
[6] Liu S, Lai W, Shi Y, et al. Annotation and cluster analysis of long noncoding RNA linked to male sex and estrogen in cancers[J]. NPJ Precis Oncol, 2020, 4(3):5-17. DOI:10.1038/s41698-020-0110-5.
[7] Wu J, Miao J, Ding Y, et al. MiR-4458 inhibits breast cancer cell growth, migration, and invasiveness by targeting CPSF4[J]. Biochem Cell Biol, 2019, 97(6):722-730. DOI:10.1139/bcb-2019-0008.
[8] Ferrè F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction[J]. Brief Bioinform, 2016, 17(1):106-116. DOI:10.1093/bib/bbv031.
[9] Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases[J]. J Cell Mol Med, 2018, 22(12):5768-5775. DOI:10.1111/jcmm.13866.
[10] Botti G, Marra L, Malzone MG, et al. LncRNA HOTAIR as Prognostic Circulating Marker and Potential Therapeutic Target in Patients with Tumor Diseases[J]. Curr Drug Targets, 2017, 18(1):27-34. DOI:10.2174/1389450117666151209122950.
[11] Ishay-Ronen D, Diepenbruck M, Kalathur RKR, et al. Gain fat-lose metastasis:converting invasive breast cancer cells into adipocytes inhibits cancer metastasis[J]. Cancer Cell, 2019, 35(1):17-32. DOI:10.1016/j.ccell.2018.12.002.
[12] Li H, Xu K, Pian G, et al. Artesunate and sorafenib:Combinatorial inhibition of liver cancer cell growth[J]. Oncol Lett, 2019, 18(5):4735-4743. DOI:10.3892/ol.2019.10810.
[13] Yu L, Liu Z, Qiu L,et al. Ipatasertib sensitizes colon cancer cells to TRAIL-induced apoptosis through ROS-mediated caspase activation[J]. Biochem Biophys Res Commun, 2019, 519(4):812-818. DOI:10.1016/j.bbrc.2019.09.063.
[14] Qiu M, Xue C, Zhang L. Piperine alkaloid induces anticancer and apoptotic effects in cisplatin resistant ovarian carcinoma by inducingG2/M phase cell cycle arrest, caspase activation and inhibition of cell migration and PI3K/Akt/GSK3β signalling pathway[J]. J BUON, 2019, 24(6):2316-2321.
[15] Zhao W, Tang L, Gao S, et al. Junduqing extractive promotes the apoptosis of nasopharyngeal carcinoma cells through down-regulating Mcl-1 and Bcl-xL and up-regulating Caspase-3, Caspase-8 and Caspase-9[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1):3904-3912. DOI:10.1080/21691401.2019.1667815.
[16] Zhao L, Niu H, Liu Y, et al. LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells[J]. J Cancer, 2019, 10(26):6481-6490. DOI:10.7150/jca.33223.
[17] Dofara SG, Chang SL, Diorio C. Gene Polymorphisms and circulating levels of MMP-2 and MMP-9:a review of their role in breast cancer risk[J]. Anticancer Res, 2020, 40(7):3619-3631. DOI:10.21873/anticanres.14351.
[18] Wang XJ, Zeng B, Lin S, et al. An integrated miRNA-lncRNA signature predicts the survival of stage Ⅱ colon cancer[J]. Ann Clin Lab Sci, 2019, 49(6):730-739.
[19] Zhong G, Lou W, Yao M, et al. Identification of novel mRNA-miRNA-lncRNA competing endogenous RNA network associated with prognosis of breast cancer[J]. Epigenomics, 2019, 11(13):1501-1518. DOI:10.2217/epi-2019-0209.
[20] Zhao Y, Feng C, Li Y, et al. LncRNA H19 promotes lung cancer proliferation and metastasis by inhibiting miR-200a function[J]. Mol Cell Biochem, 2019, 460(1-2):1-8. DOI:10.1007/s11010-019-03564-1.
[21] Zhao X, Tang DY, Zuo X, et al. Identification of lncRNA-miRNA-mRNA regulatory network associated with epithelial ovarian cancer cisplatin-resistant[J]. J Cell Physiol, 2019, 234(11):19886-19894. DOI:10.1002/jcp.28587.
[22] Wu M, Tang Y, Hu G, et al. miR-4458 directly targets IGF1R to inhibit cell proliferation and promote apoptosis in hemangioma[J]. Exp Ther Med, 2020, 19(4):3017-3023. DOI:10.3892/etm.2020.8546.
[23] Zhang Y, Shi K, Liu H, et al. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1[J]. Acta Biochim Biophys Sin (Shanghai), 2020, 52(5):554-562. DOI:10.1093/abbs/gmaa029.